In lieu of the potential implications of obesity and its related factors on the development of prostate cancer, we investigated in a prospective pilot study whether body mass index (BMI) and serum lipid profile might have a role in optimising prostate cancer diagnosis when combined with serum PSA level. The gene discussed is KLK3; the disease is prostate carcinoma.